Class 4 Medicines Defect Notification: Ipca Laboratories UK Limited, Various Products, El(25)a/42

Recall Summary Ipca Laboratories UK Limited is recalling several medicines because their Patient Information Leaflets are missing required safety information. The affected products were distributed in the United Kingdom. This is classified as a Class III defect, meaning the missing information could potentially affect patient safety.

Recalling firm
Ipca Laboratories UK Limited
Reason
Ipca Laboratories UK Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in the products listed in this notification do not contain all the required safety information.
Classification
Class III
Category
drug recall
Country
United Kingdom
Agency
UK Medicines and Healthcare products Regulatory Agency
Recall date
2025-08-26
Status
Ongoing
Distribution
United Kingdom

Official recall notice from UK Medicines and Healthcare products Regulatory Agency

Recall details on Nibble Recalls: https://trynibble.app/recalls/7c228e2b-6aae-44d9-9a5e-9ef34725124c